Categories for Male Contraception

Blog

Male Contraception Initiative RFA is Now Open
MCI's 2019 FRA is open for submission. This funding will support research in reversible, non-hormonal male contraceptive discovery and development. MCI intends to fund up to five grants, ranging from $150,000 to $300,000 over two years. MCI's Priori... Read full article
Blog

One contraceptive for both men and women
YourChoice Therapeutics is attempting to revolutionize birth control options for women and men by developing options that are hormone-free, safe, easy to use, and effective. In men, the product disables the flagellated tail, inhibiting sperm motility... Read full article
Blog

Sperm Motility Inhibited in Study of Male Macaques
Male contraceptive targets under development focus on sperm production or sperm delivery (blockage or loss of function).  One protein of particular interest is EPPIN, found on the... Read full article
Blog

Male Contraceptives in the Pipeline
Guest blog contributor is Deb Levine, BSW, MA, Interim Executive Director of the Male Contraception Initiative
The idea of male contraception has been around for 60 years. Gregory Pincus, the co-inventor of the female contraceptive... Read full article
Blog

Male Contraception Initiative Awards Four Research Grants
The Male Contraception Initiative (MCI) will fund four research teams working to develop a new reversible non-hormonal birth control pill for men.  Principal investigators include Dr. Patricia Cuasnic... Read full article
Blog

Why Male Contraception?
Guest Contributor, Deb Levine, BSW, MA, had been embedded in reproductive health work for 15+ years, before taking a position on the board of directors for the Male Contraception Initiativ... Read full article
Blog

Happy World Vasectomy Day!
Female sterilization is the most widely used contraceptive method in the world—more than 235 million women opt for it each year and its usage continues to increase.  Meanwhile, vasectomy—t... Read full article
Blog

Vibliome Therapeutics Wins MCI Research Grant
Scientists at Vibliome Therapeutics are investigating a drug candidate that is a highly selective inhibitor of HIPK4 (Homeodomain-Interacting Protein Kinase 4), a gene essential for male fertility. Earlier resea... Read full article
Blog

Hurdles Remain in Quest for New Male Contraceptives
Development of a new male contraceptive remains a hot topic, despite ongoing business and scientific obstacles.  Earlier this month, the Journal of the American Medical Association published Rita R... Read full article